CEL-SCI Corp letter to shareholders details positive results from Phase 3 study of Multikine - Geert R. Kersten Director and Chief Executive Officer, CEL-SCI Corp 00:00:00
Geert Kersten has served in his current leadership role at CEL-SCI since 1995. Mr. Kersten has been with CEL-SCI from the early days of its inception since 1987. He has been involved in the pioneering field of cancer immunotherapy for almost two decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry.
